We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Oxford BioDynamics (OBDs) has signed a collaboration agreement with Italian research and biomedical institute Casa Sollievo della Sofferenza to develop a diagnostic biomarker assay for Autism Spectrum Disorder (ASD).